Search
Ironwood Pharmaceuticals Inc
IRWDAdd to Watchlist
4.190USD
-0.080-1.87%
Close 09-23 16:00（ET）
689.72MMarket Cap
6.65P/E TTM
Ironwood Pharmaceuticals Inc (IRWD) Stock Price Target & Forecast
Analyst Rating
Based on 4 analysts giving stock ratings to Ironwood Pharmaceuticals Inc in the past month.
Buy
0 Strong Buy
2 Buy
2 Hold
0 Sell
0 Strong Sell
Target Price
6.100USD+42.86%
IRWD Analyst Recommendation Trends
In the current month, IRWD has received 2 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. IRWD average Analyst price target in the last month is 6.100.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
4
4
4
4
4
4
IRWD Analyst Rating for Peer Comparison
Updated: Sep 24, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
7
17
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Financial Forecasting
Based on analysts' estimates, IRWD EPS is projected to reach 0.323 in FY2026Q3, following reported EPS of 0.312 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.01
0.24
0.36
0.32
0.34
Actual
-0.02
0.25
0.31
--
--
Surprise
-288.50%
+3.94%
-12.37%
--
--
FAQs
What is Ironwood Pharmaceuticals Inc's expected revenue for the next quarter?
Ironwood Pharmaceuticals Inc's expected revenue is 121.57M.
What is Ironwood Pharmaceuticals Inc's price target?
Analysts forecast that Ironwood Pharmaceuticals Inc's price target is USD 6.10, with the highest forecast at USD 10.00 and the lowest forecast at USD 3.70.
How have Ironwood Pharmaceuticals IncIRWD's recent earnings per share performed?
The market expectation was USD 0.31, while Ironwood Pharmaceuticals IncIRWD's earnings per share (EPS) for the previous quarter was USD 0.25. EPS for the next quarter is expected at USD 0.32.
What is the analyst rating for Ironwood Pharmaceuticals Inc?
Based on the ratings of Ironwood Pharmaceuticals Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.